Logo image of STAA

STAAR SURGICAL CO (STAA) Stock Fundamental Analysis

NASDAQ:STAA - Nasdaq - US8523123052 - Common Stock - Currency: USD

26.9  -0.12 (-0.44%)

After market: 26.9 0 (0%)

Fundamental Rating

4

Taking everything into account, STAA scores 4 out of 10 in our fundamental rating. STAA was compared to 187 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for STAA as it has an excellent financial health rating, but there are worries on the profitability. STAA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

STAA had negative earnings in the past year.
STAA had a negative operating cash flow in the past year.
Of the past 5 years STAA 4 years were profitable.
In the past 5 years STAA always reported a positive cash flow from operatings.
STAA Yearly Net Income VS EBIT VS OCF VS FCFSTAA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -15.54%, STAA is in line with its industry, outperforming 54.01% of the companies in the same industry.
STAA has a better Return On Equity (-20.31%) than 60.43% of its industry peers.
Industry RankSector Rank
ROA -15.54%
ROE -20.31%
ROIC N/A
ROA(3y)3.25%
ROA(5y)3.83%
ROE(3y)4.04%
ROE(5y)4.92%
ROIC(3y)N/A
ROIC(5y)N/A
STAA Yearly ROA, ROE, ROICSTAA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

STAA's Gross Margin of 74.00% is amongst the best of the industry. STAA outperforms 85.56% of its industry peers.
STAA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for STAA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.5%
GM growth 5Y0.47%
STAA Yearly Profit, Operating, Gross MarginsSTAA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

STAA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for STAA has been increased compared to 1 year ago.
The number of shares outstanding for STAA has been increased compared to 5 years ago.
STAA has a better debt/assets ratio than last year.
STAA Yearly Shares OutstandingSTAA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
STAA Yearly Total Debt VS Total AssetsSTAA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 8.07 indicates that STAA is not in any danger for bankruptcy at the moment.
STAA's Altman-Z score of 8.07 is amongst the best of the industry. STAA outperforms 88.24% of its industry peers.
There is no outstanding debt for STAA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.07
ROIC/WACCN/A
WACC8.86%
STAA Yearly LT Debt VS Equity VS FCFSTAA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 4.78 indicates that STAA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.78, STAA is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
STAA has a Quick Ratio of 4.07. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of STAA (4.07) is better than 73.80% of its industry peers.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 4.07
STAA Yearly Current Assets VS Current LiabilitesSTAA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

STAA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -145.31%.
Measured over the past 5 years, STAA shows a small growth in Earnings Per Share. The EPS has been growing by 7.49% on average per year.
STAA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.44%.
The Revenue has been growing by 15.88% on average over the past years. This is quite good.
EPS 1Y (TTM)-145.31%
EPS 3Y-12.35%
EPS 5Y7.49%
EPS Q2Q%-688.89%
Revenue 1Y (TTM)-14.44%
Revenue growth 3Y10.84%
Revenue growth 5Y15.88%
Sales Q2Q%-44.94%

3.2 Future

STAA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.71% yearly.
Based on estimates for the next years, STAA will show a small growth in Revenue. The Revenue will grow by 5.19% on average per year.
EPS Next Y-634.34%
EPS Next 2Y-56.85%
EPS Next 3Y4.01%
EPS Next 5Y22.71%
Revenue Next Year-25.8%
Revenue Next 2Y-3.26%
Revenue Next 3Y0.22%
Revenue Next 5Y5.19%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
STAA Yearly Revenue VS EstimatesSTAA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
STAA Yearly EPS VS EstimatesSTAA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

STAA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STAA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STAA Price Earnings VS Forward Price EarningsSTAA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STAA Per share dataSTAA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-56.85%
EPS Next 3Y4.01%

More info and screens

0

5. Dividend

5.1 Amount

STAA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STAAR SURGICAL CO

NASDAQ:STAA (8/6/2025, 4:30:01 PM)

After market: 26.9 0 (0%)

26.9

-0.12 (-0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners109.32%
Inst Owner Change-0.06%
Ins Owners0.38%
Ins Owner Change18.26%
Market Cap1.33B
Analysts71.58
Price Target19.48 (-27.58%)
Short Float %12.7%
Short Ratio8.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1693.07%
Min EPS beat(2)-3398.76%
Max EPS beat(2)12.63%
EPS beat(4)3
Avg EPS beat(4)-804.54%
Min EPS beat(4)-3398.76%
Max EPS beat(4)120.44%
EPS beat(8)5
Avg EPS beat(8)-392.44%
EPS beat(12)9
Avg EPS beat(12)-233.83%
EPS beat(16)12
Avg EPS beat(16)-144.65%
Revenue beat(2)1
Avg Revenue beat(2)-17.15%
Min Revenue beat(2)-37.91%
Max Revenue beat(2)3.61%
Revenue beat(4)2
Avg Revenue beat(4)-8.1%
Min Revenue beat(4)-37.91%
Max Revenue beat(4)3.61%
Revenue beat(8)3
Avg Revenue beat(8)-4.68%
Revenue beat(12)4
Avg Revenue beat(12)-2.78%
Revenue beat(16)6
Avg Revenue beat(16)-1.16%
PT rev (1m)-13.77%
PT rev (3m)-13.43%
EPS NQ rev (1m)1.26%
EPS NQ rev (3m)-13.59%
EPS NY rev (1m)-10.2%
EPS NY rev (3m)-95.69%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-1.14%
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)-2.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.77
P/FCF N/A
P/OCF N/A
P/B 3.81
P/tB 3.83
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS5.64
BVpS7.07
TBVpS7.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.54%
ROE -20.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74%
FCFM N/A
ROA(3y)3.25%
ROA(5y)3.83%
ROE(3y)4.04%
ROE(5y)4.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.5%
GM growth 5Y0.47%
F-Score2
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 246.03%
Cap/Sales 7.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.78
Quick Ratio 4.07
Altman-Z 8.07
F-Score2
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)365.33%
Cap/Depr(5y)348.39%
Cap/Sales(3y)6.49%
Cap/Sales(5y)6.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.31%
EPS 3Y-12.35%
EPS 5Y7.49%
EPS Q2Q%-688.89%
EPS Next Y-634.34%
EPS Next 2Y-56.85%
EPS Next 3Y4.01%
EPS Next 5Y22.71%
Revenue 1Y (TTM)-14.44%
Revenue growth 3Y10.84%
Revenue growth 5Y15.88%
Sales Q2Q%-44.94%
Revenue Next Year-25.8%
Revenue Next 2Y-3.26%
Revenue Next 3Y0.22%
Revenue Next 5Y5.19%
EBIT growth 1Y-295.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-543.45%
EBIT Next 3Y80.58%
EBIT Next 5Y67.76%
FCF growth 1Y-286.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-133.17%
OCF growth 3Y-29.01%
OCF growth 5Y-9.43%